Clinical Scorecard: Exploring the Diagnostic and Referral Practices of General Practitioners for Suspected Rheumatic Musculoskeletal Disorders: A Scoping Review
At a Glance
Category
Detail
Condition
Rheumatic Musculoskeletal Disorders (RMDs)
Key Mechanisms
Diagnostic delays and referral inefficiencies in primary care for inflammatory rheumatic diseases.
Target Population
Patients presenting with RMD-related complaints in primary care.
Care Setting
Primary care settings.
Key Highlights
RMDs account for significant years lived with disability and impact quality of life.
Diagnostic delays for conditions like rheumatoid arthritis can exceed 6-12 months.
High referral rates to rheumatology often involve patients without an inflammatory rheumatic disease.
Guidelines and decision-support tools exist to improve diagnostic accuracy and referral efficiency.
Understanding the diagnostic trajectory in primary care is essential for improving care.
Guideline-Based Recommendations
Diagnosis
Utilize clinical symptoms for diagnosing inflammatory rheumatic diseases.
Implement decision-support tools to assist in identifying patients for referral.
Management
Focus on early recognition of RMDs to initiate timely treatment.
Monitoring & Follow-up
Regularly assess the diagnostic process to identify bottlenecks.
Risks
Delayed diagnosis can lead to preventable joint damage and loss of quality of life.
Patient & Prescribing Data
Individuals with suspected inflammatory rheumatic diseases.
Advances in early and targeted treatments have improved outcomes for inflammatory rheumatic diseases.
Clinical Best Practices
Enhance GP knowledge and awareness of inflammatory rheumatic diseases.
Streamline referral processes to reduce unnecessary consultations.
High-revision-rate surgeons saw a late revision signal after adopting robotic-assisted total knee arthroplasty, despite no overall reduction in revision rates or failure modes.
The approval was based on reduced proteinuria, and an ongoing trial is required to determine whether atacicept slows long-term kidney function decline.
